5.27 USD
↘ 0.12 (2.23%)AT CLOSE (03:59 PM EDT)
Kyverna Therapeutics, Inc. Common Stock
KYTXNASDAQ • USD
5.26
↘ 0.01 (0.28%)
POST MARKET (AS OF 07:30 PM EDT)
Post Market
AS OF 07:30 PM EDT
5.26
↘ 0.01 (0.28%)
Market: CLOSED
Kyverna Therapeutics, Inc. Common Stock (KYTX) trades at $5.26 per share. Both sides of the analysis point lower: technicals flash "Strong Sell" and fundamentals confirm with a "Sell" reading. This is driven by a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. Valuation metrics suggest KYTX is trading at a discount to its peers, earning an "Attractively Valued" rating.
Technical & fundamental data as of Oct 26, 2026.
Open?$5.35
High?$5.41
Low?$5.18
Prev. Close?$5.39
Volume?810.1K
Avg. Volume?942.4K
VWAP?$5.26
Rel. Volume?0.86x
Bid / Ask
Bid?$4.46 × 100
Ask?$6.06 × 100
Spread?$1.60
Midpoint?$5.26
Valuation & Ratios
Market Cap?333.3M
Shares Out?61.8M
Float?36.8M
Float %?60.5%
P/E Ratio?N/A
P/B Ratio?2.01
EPS?-$2.47
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Kyverna Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is focused on developing cell therapies for patients suffering from autoimmune diseases. Its product, KYV-101, is an autologous CD19 CAR T-cell product candidate made from an underlying chimeric antigen receptor, or CAR. It is also developing KYV-201, an allogeneic therapy containing the same CAR as KYV-101, to develop it in multiple autoimmune diseases.
Themes
Employees
149
Market Cap
333.3M
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Website
Listed
2024-02-08
Address
5980 HORTON STREET
EMERYVILLE, CA
Phone: (510) 925-2492
EMERYVILLE, CA
Phone: (510) 925-2492
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-3/3)
Medium-Term (Wave)?▼ Bearish(-3/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?1
Momentum?77
Short Sent.?10
Piotroski F-Score?0/9Weak
Altman Z-Score?-0.90Distress
Confidence?49%Low
Short InterestSqueeze Risk
Short % of Float?25.95%Squeeze Risk
Short Interest?9.5M
Days to Cover?10.5
Free Float36.8M
Avg Daily Volume909.7K
Settlement Date2026-10-15
Financial Health
Current Ratio?9.06Strong
Quick Ratio?9.06Strong
Cash Ratio?1.39Strong
Debt/Equity?0.15Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score100/100
P/E?N/A▾
P/B?2.01CHEAP▾
Peers100
S&P74
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?-2.1CHEAP▾
S&P97
EV/Sales?N/A▾
Returns & Efficiency
ROE?-92.2%WEAK▾
S&P3
ROA?-69.4%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-159045000
Enterprise Value?$326.5M
Fundamentals ratios updated end of day